Research, Value, and Flexibility Investing
Research deeply, price the future, and pivot when facts change
- Difficulty
- Advanced
- Time to result
- ~months to results
- Steps
- 6
- Confidence
- 97%
The framework combines three disciplines Jean Hynes learned from Ed Owens. First, conduct deep research across companies, countries, and market capitalizations to build a richer mosaic of how an industry or technology is evolving. Second, translate that future into an estimate of what the enterprise could be worth, then compare that value with the security’s current price. A compelling scientific concept is not sufficient unless the valuation leaves room for investor returns. Third, remain flexible after investing. A long holding period should reflect a durable thesis rather than complacency; when material evidence changes the thesis, update the valuation and position. The output is a researched, price-aware investment decision that can evolve with the facts.
Origin
Jean Hynes developed this approach during twenty years working with healthcare investor Ed Owens, who combined global scientific research, value discipline, and a willingness to change his mind. Extracted from Masters in Business.
Core principles
- 01Research globally and across market capitalizations
- 02Build a mosaic from multiple companies and markets
- 03Translate future developments into enterprise value
- 04Buy securities at attractive prices, not exciting concepts
- 05Change the thesis when material evidence changes
How to run it
- 1
Define the value-creating change
Identify the scientific, competitive, or market development that could materially change the company’s future. State the causal thesis clearly enough that subsequent evidence can confirm or challenge it.
Pro tip Describe the future change before looking at the current valuation.
Watch out Do not treat a broad trend as proof that one company will benefit.
- 2
Build a global research mosaic
Study relevant companies across geographies and market capitalizations. Compare parallel products, mechanisms, competitors, and market developments to test whether the opportunity is real.
Pro tip Look for small or foreign companies working on the same underlying problem.
Watch out Researching only the target company can reinforce management’s preferred narrative.
- 3
Estimate future enterprise value
Model what the company could be worth if the thesis succeeds, including realistic probabilities, market share, and economic outcomes. Focus on intrinsic value rather than simplistic low-multiple labels.
Pro tip Use multiple scenarios instead of relying on one forecast.
Watch out Do not confuse a large potential market with value captured by the company.
- 4
Compare value with price
Tie the fundamental outlook back to the current security price. Invest only when the gap between price and expected value provides adequate room for client returns.
Pro tip Make the required margin explicit before buying.
Watch out A transformative technology can still be a poor investment at an excessive price.
- 5
Monitor the long-term thesis
Track the evidence most capable of changing the original assumptions. Distinguish temporary market noise from developments that alter the company’s long-term value.
Pro tip Write down thesis-breaking conditions in advance.
Watch out A long-term orientation must not become an excuse for ignoring contrary evidence.
- 6
Pivot when facts change
Update the thesis, valuation, and position when new information materially changes the outlook. Flexibility protects the portfolio from commitment to obsolete assumptions.
Pro tip Reassess as though evaluating the investment for the first time.
Watch out Time already spent researching or holding a stock is a sunk cost.
In the wild
An investor studying a biotechnology company maps every business pursuing the same mechanism, including a small San Diego firm and a Japanese competitor. Clinical evidence from the wider group reveals whether the mechanism works and which company has the strongest product. The investor then probability-weights the target company’s potential sales and compares the resulting value with its stock price.
→ The decision reflects both the scientific evidence and the price required to earn an adequate return.
A portfolio has owned a medical-device company for three years because it was expected to gain market share. New evidence shows that a competitor’s product has permanently changed physician adoption. Rather than defending the original work, the team rebuilds its scenarios, finds the expected value below the market price, and reduces the position.
→ The portfolio responds to a changed long-term thesis instead of allowing tenure to become complacency.
Common mistakes
Buying the concept instead of the stock
An investor may correctly predict a medical breakthrough yet overpay for the company producing it. The framework requires a direct comparison between enterprise value and the current stock price.
Researching in a geographic silo
Ignoring companies in other regions leaves gaps in the evidence and can obscure better competitors or contradictory findings.
Confusing patience with rigidity
Long-term investing fails when commitment to an old thesis prevents action after material facts change.
Is it for you?
Best for
It is best for long-term fundamental investors evaluating innovative or research-intensive companies.
Not ideal for
It is not ideal for purely technical, momentum-driven, or very short-term trading strategies.
From the transcript
“that really helped us build mosaics.”
“our job is not to predict the future of medicine. Our job is to buy stock um, not concepts.”
“He was just very flexible to change his mind when something changed our long term thesis.”
From the episode
Jean Hynes, Wellington’s Incoming CEO (Podcast)
Jean Hynes